Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-25-014757

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Swirsky Douglas J Director 2025-02-14 Grant or award · Stock option (right to buy) +90,000 90,000 D
Loading xslF345X05/tm256830-8_4seq1.xml…